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Abstract
Background: Infection with Plasmodium berghei ANKA (PbA) in susceptible mice induces a syndrome called experimental
cerebral malaria (ECM) with severe pathologies occurring in various mouse organs. Immune mediators such as T cells or
cytokines have been implicated in the pathogenesis of ECM. Red blood cells infected with PbA parasites have been shown
to accumulate in the brain and other tissues during infection. This accumulation is thought to be involved in PbA–induced
pathologies, which mechanisms are poorly understood.
Methods and Findings: Using transgenic PbA parasites expressing the luciferase protein, we have assessed by real-time in
vivo imaging the dynamic and temporal contribution of different immune factors in infected red blood cell (IRBC)
accumulation and distribution in different organs during PbA infection. Using deficient mice or depleting antibodies, we
observed that CD8
+ T cells and IFN-c drive the rapid increase in total parasite biomass and accumulation of IRBC in the brain
and in different organs 6–12 days post-infection, at a time when mice develop ECM. Other cells types like CD4
+ T cells,
monocytes or neutrophils or cytokines such as IL-12 and TNF-a did not influence the early increase of total parasite biomass
and IRBC accumulation in different organs.
Conclusions: CD8
+ T cells and IFN-c are the major immune mediators controlling the time-dependent accumulation of P.
berghei-infected red blood cells in tissues.
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Introduction
Malaria remains one of the most health-threatening diseases
worldwide and is a major global cause of morbidity and mortality,
with ,800 000 deaths worldwide each year [1,2]. Patients with
severe Plasmodium falciparum malaria develop complications like
acidosis, edema, respiratory problems, jaundice, hypoglycemia
and cerebral malaria (CM) [3]. CM is the most severe
complication of P. falciparum infection, afflicting primarily children
aged 2–6 years in sub-Saharan Africa, adults in Southeast Asia and
pregnant women [3]. Clinically, it is defined as a diffuse
encephalopathy causing unrousable coma often associated with
seizures in the presence of asexual forms of P. falciparum in
peripheral blood and not attributable to other causes of
unconsciousness [3]. The mechanisms leading to CM in humans
are not completely understood and two main hypotheses, one
mechanical and one immunological, have been proposed and are
still actively debated [4–6]. The mechanical hypothesis is based on
the observation that mature infected red blood cells (IRBC) bind
to the endothelium of the brain and other organs [7]. IRBC
cytoadherence is responsible for the intravascular sequestration of
mature asexual forms in tissues and their disappearance from the
peripheral circulation [8–10]. Thus, it has been proposed that
accumulation of sequestered IRBC causes obstruction of brain
microvessels leading to decreased blood flow, hypoxia, hemor-
rhages, coma and death [10]. However, it has been reported that
some patients clinically diagnosed with human cerebral malaria
had little or no IRBC sequestered in their brain capillaries [11,12],
suggesting that IRBC sequestration might not be sufficient per se
to cause CM. The immunological hypothesis is based on the
findings that i) a strong inflammatory response, characterized by
elevated levels of pro-inflammatory cytokines [13,14], is observed
during the acute phase of P. falciparum infection and ii) leukocytes
and platelets, together with IRBC, were found sequestered
intravascularly not only in the brain microvessels of CM patients
[15,16], but also in other organs such as the lungs [11]. IRBC and
malaria toxins stimulate immune cells to produce large amounts of
pro-inflammatory cytokines such as TNF-a, IFN-c and lympho-
toxin-a [6]. These inflammatory cytokines induce the production
of chemokines and up-regulate the expression of some adhesion
molecules, such as ICAM-1 and/or VCAM-1 on endothelial cells
in ECM [17]. Chemokines are responsible for the attraction of
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adhesion molecules mediate the cytoadherence and sequestration
of these immune cells in the brain and other organs. Inflamma-
tion-induced adhesion molecules of the endothelium, such as
ICAM-1, can also act as ligands for cytoadherent IRBC [18,19],
thus bridging the mechanical and the immunological hypotheses.
Ethical concerns limit the analysis of pathogenic mechanisms
leading to CM at the tissue level. Therefore many mechanistic
studies have relied on the use of rodent malaria models [20] which
allow access to deep tissues. Susceptible mice infected with P.
berghei ANKA develop a severe syndrome with cerebral pathology
leading to coma and death. This experimental cerebral malaria
(ECM) model is characterized by the intravascular accumulation
of immune cells in the brains of mice which die during the first 10
days of infection with signs of neurological involvement [20] and
evidence of circulatory shock [21]. Different cell subsets such as
monocytes, NK, neutrophils and T cells have been shown to
migrate to the brain coincident with the neurological signs of
ECM [22,23]. CD8
+ T cells have been shown to be the primary
effectors of ECM [22], whereas NK and CD4
+ T cells have been
implicated in the induction phase of ECM [22,23]. Pro-
inflammatory cytokines such as IFN-c [24] and lymphotoxin-a
[25] are also essential for ECM to occur.
The precise role of IRBC accumulation in ECM pathogenesis is
still unknown. PCR-based methods were first used to demonstrate
that parasites accumulate in the brain during infection [26,27];
this was subsequently confirmed by histological studies [28].
Recently, dynamic investigation of IRBC distribution in organs
during the course of infection has been made possible by
bioluminescence imaging using transgenic PbA parasites express-
ing luciferase [29]. The pioneer study by Franke-Fayard et al. [30]
detected IRBC accumulation in various organs during infection
but concluded that ECM was unrelated to IRBC accumulation
because of the low signal in the brain. However, recent studies
[31,32] and our unpublished results have clearly demonstrated
IRBC accumulation in the brain when imaging parameters were
optimized. Whereas there is considerable evidence that IRBC
sequestration induces pro-inflammatory cytokine and chemokine
secretion and the recruitment of immune cells (reviewed in [6]),
whether inflammation and immune cells in turn contribute to
IRBC accumulation remains an unresolved question. In this
paper, we report the results of our bioluminescence imaging
experiments showing that CD8
+ T cells and IFN-c drive IRBC
accumulation in the brain and also in other organs only for the
duration of ECM.
Materials and Methods
Ethics
All experiments and procedures were approved by the
Institutional Animal Care and Use Committee (IACUC) of
A*STAR (Biopolis, Singapore) (Authorization No IACUC
080321) in accordance with the guidelines of the Agri-Food and
Veterinary Authority (AVA) and the National Advisory Commit-
tee for Laboratory Animal Research (NACLAR) of Singapore.
Mice
Female or male wild-type (WT) and CD8
2/2, CD4
2/2,
Rag2
2/2, CCR2
2/2, IFN-c
2/2, IL12p40
2/2, and TNFa
2/2
deficient C57BL/6J mice were used. MAFIA (macrophage Fas-
induced apoptosis) mice on a C57BL/6J background [33] were
also used. All mice (7–8 wk old) were bred and kept under specific
pathogen-free conditions in the Biomedical Resource Centre,
Singapore.
Parasite infection and evaluation of the disease
The transgenic Plasmodium berghei ANKA (231c1l) line expressing
luciferase and green fluorescent proteins under control of the ef1-a
(PbAluc) used in this study was kindly provided by Dr. Christian
Engwerda (QIMR, Brisbane, Australia) [30,31]. IRBC stabilates
used to initiate infections were free from other infectious agents
and were prepared through in vivo passage in C57BL/6J mice and
stored in liquid nitrogen (10
7 IRBC/ml in Alseveer’s solution)
[34]. All mice were infected intraperitoneally with 10
6 IRBC.
Parasitemia was monitored daily by flow cytometry starting from
day 3 till day 12, and afterwards every 2 days till day 30. From day
3 to day 5, 5610
5 cells were acquired and from day 6 onwards,
10
5 cells. Sixty- to 100% of susceptible mice of the C57BL/6J
background developed ECM depending on the experiments and
on the parasite batch used to initiate infection. Mice were
considered to have ECM if they displayed the following
neurological symptoms: paralysis, ataxia, deviation of the head
and convulsion and/or coma. The mice that did not develop ECM
died of hyperparasitemia and anemia later in the infection.
In vivo and ex vivo imaging
IRBC accumulation in mice infected with PbAluc was assessed
daily using an in vivo imaging system (IVIS, Xenogen, Alameda,
Ca). The luciferase substrate, D-luciferin potassium salt (Caliper
Life sciences), was dissolved in phosphate-buffered saline at a
concentration of 5 mg/ml. Mice were anesthetized in an oxygen-
rich induction chamber with 2% isoflurane and shaved, then
measurements were performed 2 min after subcutaneous injection
of 100 ml of luciferin. Whole body imaging was performed with the
animal in the ventral position (facing the camera) (Figure S1A).
Head imaging was performed on the animal in the dorsal position
(with the back of their head facing the camera (Figure S1B).
Bioluminescence imaging was acquired with 21.7 and 4 cm FOV
for whole body and head respectively, medium binning factor, and
exposure time of 5–60 s (changed according to the intensity of the
bioluminescence signal). For some experiments, individual organs
were removed from intracardially perfused or non-perfused mice,
3 min after a second subcutaneous injection of luciferin. Organs
were placed in 24 well plates and imaged with 10 cm FOV,
medium binning factor, and exposure times of 10–60 s. To allow
comparisons between images from different days, uninfected mice
injected with luciferin were imaged to for background subtraction.
For bioluminescence quantification, regions of interest (ROI) were
drawn by using the software Living Imaging 3.0 and average
radiance (p/s/cm
2/sr) was determined.
In vivo leukocyte subpopulation and macrophage
depletion
Purified rat IgG2b anti-mouse CD8 (clone 2.43; TIB 210;
American Type Culture Collection (ATCC), Manassas, VA) and
rat IgG2a anti-mouse CD4 (clone GK1.5; TIB 207; ATCC) mAbs
were used from stocks previously shown to efficiently deplete the
relevant T cell subsets [35]. A total of 1 mg of mAbs was injected
intraperitoneally at day 6 after parasite infection, before the onset
of CM. The non–depleting anti-mouse M-CSF receptor mAb
(AFS98) [36] was used to prevent monocyte accumulation into
tissues [37,38] by injecting 2 mg intraperitoneally at day 5 and 6
post-infection. For monocyte/granulocyte depletion in MAFIA
mice, the nontoxic, cell-permeable small dimerizer drug AP20187
(a gift from Ariad Pharmaceuticals) was used. A stock solution of
13.75 mg/ml AP20187 in ethanol was diluted to 0.55 mg/ml in
4% ethanol, 10% PEG-400, and 1.7% Tween in water. The mice
were intraperitoneally injected at day 5, 6 and 7 after parasite
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to deliver 10 mg AP20187 per kg mouse. It has to be noted that
CD115 has been shown to be expressed in microglial cells [39].
However, although the inducible suicide transgene was clearly
expressed in resident brain macrophages, treatment with the
dimerizing agent did not induce deletion of microglial cells
(identified here as CD45-CD11b+) in our experiment or in
previous studies [33]. CD115 is also expressed by neurons in
mouse brain [40]. However, treatment of normal MAFIA mice
with the dimerizing agent did not induce any neurological
manifestations or alterations [33]. This is probably due the limited
capacity of the dimerizing drug to cross the blood-brain barrier
and access brain parenchyma.
Purification of tissue and blood leukocytes
Mice were perfused intracardially with PBS to remove
circulating RBC, IRBC and leukocytes. Organs were removed
and processed as previously described [22]. For the blood, 50 to
100 ml was collected into PBS 10 mM EDTA to prevent clotting.
Red blood cells were removed by incubation in a buffered
ammonium chloride (ACK) solution and cells washed with FACS
buffer (PBS 1% BSA 2 mM EDTA). Pellet was resuspended into
100 ml blocking buffer (FACS buffer containing 1% rat and mouse
serum). After 30 minutes incubation on ice, cells were stained for
FACs analysis. For live/dead discrimination, cells were resus-
pended in 200 to 300 ml FACS buffer containing DAPI (0.1 mg/
ml).
Flow cytometry analysis
Flow cytometry studies were performed using LSR II (Becton
Dickinson) and subsequently analyzed using the FlowJo software
(Tree Star). Fluorochrome or biotin-conjugated monoclonal
antibodies (mAbs) specific for mouse CD11b (clone M1/70),
CD45 (clone 30F11), CSF-1R (or CD115) (clone AFS98), Gr-1/
Ly6C/G (clone RB6-8C5), the corresponding isotype controls and
the secondary reagents (phycoerythrin coupled to streptavidin)
were purchased either from BD Biosciences or e-biosciences. Anti-
F4/80 (A3-1) mAb was purchased from Serotec. Analysis was
carried out by gating on singlets DAPI– (4,6-diamidino-2-
phenylindole) CD45
+ cells.
Statistical analysis
Difference in survival was assessed with the log-rank Kaplan-
Meier test. Differences between two groups were analyzed for
statistical significance using the Mann-Whitney U test and for
multiple groups using one-way ANOVA and the Dunn post-test.
The data were analyzed using GraphPad Prism software (version
3.0) and taking p,0.05 as the level of significance.
Results
CD8
+ T cells regulate parasite accumulation in the brain
during ECM
Since immune mediators such as T cells and cytokines have
been shown to be crucial for ECM development, we tested the
hypothesis that parasite accumulation in the brain and other
organs is modulated by the immune system.
First, we assessed the role of the adaptive immune system using
RAG-2
2/2 mice which lack B and T cells. RAG2
2/2 mice
infected with PbAluc did not develop ECM contrary to wild-type
(WT) C57BL/6J mice which died with neurological signs 6 to 12
days post-infection (Figure 1A). They had significantly lower
parasitemias in peripheral blood than the WT mice during the first
week of infection and survived past the third week of infection,
eventually dying of anemia and hyperparasitemia (Figure 1B).
Parasite biomass was monitored in parallel by bioluminescence
imaging in WT and RAG2
2/2 mice. Strikingly, a strong increase
in parasite biomass was observed in WT mice when they
developed patent ECM signs (Figure 1C and 1E). In contrast,
total parasite biomass (determined by imaging the whole body)
remained low in the RAG2
2/2 mice until it increased steadily
from day 9 onwards, paralleling the increase in parasitemia. A
similar result was observed when parasite biomass measurement
was restricted to the head (Figure 1D and 1F). This demonstrated
that total and head parasite biomasses are under the control of T
or B cells during the time frame of PbA development and is clearly
associated with the development of ECM. Since previous studies
using B-deficient mice showed that these cells were not involved in
ECM pathogenesis [41], we turned our attention to mice lacking
CD4 and CD8 T cells. Eighty five percent of CD4
2/2 mice and
all of the CD8
2/2 mice failed to develop ECM (Figure 2A) even
though parasitemias were similar to those of WT mice during the
first week of infection (Figure 2B). Bioluminescence imaging
showed significantly less whole body and head parasite accumu-
lation in CD8
2/2 mice when compared to WT or CD4
2/2 mice
between days 7 and 9, at the time when WT mice started to
develop ECM (Figure 2C and D). Further quantification of IRBC
accumulation in isolated organs was performed on day 7. We
observed significantly decreased IRBC accumulation in the brain
(Figures 2A and 2F and S2A) and the spleen (Figure 2E) for
CD8
2/2 mice but not in the other organs tested (Figure S3A to
D). IRBC accumulation in the tested organs of CD4
2/2 mice was
similar to that of WT mice except for the spleen, where
accumulation was reduced (Figure S3A to D).
Previous studies have shown that depletion of CD8
+ but not
CD4
+ T cells 6 days post-infection, just prior to the onset of
neurological signs, prevents the development of ECM [22]. Thus,
we applied these treatments to PbAluc-infected mice and measured
IRBC accumulation when untreated mice developed clinical signs
of ECM. None (out of 5) of the infected mice depleted with anti-
CD8 developed ECM. On the contrary, most mice (3 out of 5)
depleted with anti-CD4 mAbs developed ECM, to the same extent
as WT C57BL/6 mice (7 out of 8 mice). Parasitemia developed
similarlyincontrolgroupsand inCD4
+- andCD8
+-depletedgroups
(data not shown). This confirmed previous results [22]. In
agreement with the data above using deficient mice, significantly
fewer IRBC were accumulated in the bodies and heads of CD8
+
-depleted mice than in WT or CD4
+ -depleted mice (Figure 3A and
3B). Fewer IRBC were detected in isolated brains (Figure 3D and
2B), spleens (Figure 3C) and in other organs tested (liver, lungs,
kidneys and heart) of CD8
+-depleted mice as compared to WT or
CD4
+-depleted mice (Figures S2B and S3E to H). Although IRBC
accumulation in the brain and spleen were similar for CD8
2/2 and
CD8-depleted mice, the absence of differences in other organs
tested from CD8
2/2 mice suggest that compensatory mechanisms
that lead to parasite accumulation may develop in these mice.
Taken together, our results show that CD8
+ but not CD4
+ T cells
are the main cellular subset controlling IRBC accumulation in the
brain and organs. They also demonstrate that accumulation of
IRBC per se is not sufficient for ECM to occur.
Myeloid cells are not involved in IRBC accumulation in
the brain and other organs
Myeloid cells (both neutrophils and monocytes) have been shown
to accumulate at the time of ECM in the brains of infected animals
[22]. Since these cells have the capacity to phagocytose IRBC
[42,43] and also to adhere to the activated endothelium, we tested
the possibility that increased bioluminescence signals in organs may
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2/2 mice. A) Survival and (B) parasitemia in WT
(n=5) and Rag2
2/2 mice (n=5) infected with PbAluc. Neurologic signs of CM appeared on days 6–12 (shaded area), with death occurring 24–48 h
after onset. Parasitemia (%) values are expressed as mean 6 SD of 5 mice per group. In vivo bioluminescence imaging quantification of IRBC
accumulation in the whole body (C) and head (D) of infected WT and Rag2
2/2 mice. Mice were injected with luciferin and IRBC accumulation was
measured by bioluminescence imaging as described in Materials and Methods. Each bar represents mean luminescence values (log) 6 SD of 5 mice.
#p,0.01, log-rank test and **p,0.01 and ***p,0.001, Mann Whitney test. Pseudocolor images of whole body (E) and Head (F) from infected WT and
RAG2 KO mice.
doi:10.1371/journal.pone.0018720.g001
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PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18720Figure 2. Decrease in parasite biomass and IRBC accumulation in organs in infected CD8
2/2 mice. A) Survival and (B) parasitemia of
CD8
2/2 (n=8), CD4
2/2 (n=8) and WT (n=10) mice infected with PbAluc. Neurologic signs of CM appeared on days 6–12 (shaded area), with death
occurring 24–48 h after onset. Parasitemia (%) values are expressed as mean 6 SD. In vivo bioluminescence imaging quantification of IRBC
accumulation in the whole body (C) and head (D) of infected mice. Ex vivo quantification by bioluminescence imaging of IRBC accumulation in
spleens (E) and brains (F) obtained from five perfused mice per group. Luminescence values (log) as mean 6 SD. #p,0.01, log-rank test; *p,0.05,
**p,0.01 and ***p,0.001, ANOVA followed by Bonferroni test.
doi:10.1371/journal.pone.0018720.g002
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IRBC. To do so, we took advantage of a new transgenic mouse
model, MAFIA, expressing an inducible suicide gene under the
promoter of the M-CSFR (CD115) promoter allowing conditional
ablation of myeloid CD115
+ cells after treatment with the dimerizer
cytotoxic peptide AP20187 [33]. MAFIA mice were infected with
PbAluc and treated (or not) with the dimerizer peptide. At day 8
post-infection, granulocyte/monocyte depletion was about 80%
complete in the blood (Figure S4), the brain (Figure 4A), and in the
lungs (data not shown) of treated MAFIA mice as determined by
flow cytometry. Depletion of myeloid cells did not prevent ECM
(Figure 4B) or modify parasitemia (Figure 4C). This treatment also
did not affect parasite biomass for the whole body(Figure 4D) or the
head (Figure 4E). Additional analysis on isolated organs confirmed
these findings (Figure S5). We also tested the role of myeloid cells
using CCR2
2/2 mice. These mice deficient for a chemokine
receptor are fully susceptible to ECM but have a strong reduction in
monocyte (50%) and neutrophil (100%) numbers in their brains at
the time of ECM when compared to WT mice [44]. To further
prevent residual monocyte migration to the brain during ECM, we
treated the mice with an anti-mouse M-CSF receptor mAb (AFS98)
which prevents monocyte migration into tissues without depleting
them [38,45]. CCR2
2/2 mice treated at day 5 and 6 post-infection
still die of ECM and have the same parasitemia as CCR2
2/2 non-
treated mice (Figure S6A and S6B). There were also no significant
differences in parasite biomass in the whole body and in the head
between antibody-treated and untreated mice (Figure S6C and
S6D). Our results clearly show that monocytes and neutrophils are
not involved in IRBC accumulation and confirmed that these cells
are not involved in ECM.
Figure 3. Decrease in parasite biomass and IRBC accumulation in organs from CD8
+ T cell-depleted WT mice. In vivo bioluminescence
imaging quantification of IRBC accumulation in the whole body (A) and head (B) of mice infected with PbAluc and depleted of either CD4
+ or CD8
+ T
cells by antibody treatment. Ex vivo quantification by bioluminescence imaging of IRBC accumulation in spleens (C) and brains (D). Data are
expressed as mean 6 SD. In this experiment, all the control (n=10) and CD4
+-depleted (n=5) mice infected with PbAluc developed ECM between
days 7 and 12, and none of the anti-CD8
+-treated (n=10) infected mice developed CM. On each day that a control-infected mouse developed CM,
one CD4 depleted- and one CD8-depleted mouse were sacrificed to determine IRBC accumulation ex vivo. Luminescence values (log) as mean 6 SD
of 5 mice. *p,0.05, **p,0.01 and ***p,0.001, ANOVA followed by Bonferroni test.
doi:10.1371/journal.pone.0018720.g003
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Proinflammatory cytokines, such as IFN-c [24] and lympho-
toxin-a [25] play important roles in the pathogenesis of ECM in
part by inducing CD8
+ T cell migration to the brain and other
organs [46]. However, their impact in IRBC accumulation is
unknown. We thus infected IFN-c
2/2 mice with PbAluc; these
mice were completely resistant to ECM (Figure 5A) despite
developing parasitemia levels similar to or higher than WT
(Figure 5B). Bioluminescence imaging showed that IFN-c
2/2 mice
had lower total or head parasite biomass than the WT mice, but
remarkably only during the time frame when the latter developed
ECM (Figure 5C and 5D). IRBC accumulation was assessed in
isolated organs on days 7 and 8 post-infection (at the time when
WT mice started to develop ECM). Significantly fewer IRBC were
accumulated in the brains of IFN-c
2/2 mice than in WT mice on
both days (Figures 5F and S7). In the other organs, there was no
statistically significant difference in IRBC accumulation (Figure
S8) except for the spleen, where the IFN-c
2/2 mice showed a
modest decrease in parasite biomass on day 8 (Figure 5E). The
time- and location-specific effect of IFN-c on parasite accumula-
tion strongly suggests a causative role for this cytokine in ECM
pathogenesis.
We also tested the role of two other pro-inflammatory cytokines,
namely TNF-a and IL-12 using deficient mice. Both types of mice
were fully susceptible to ECM and their parasitemias did not differ
from those of WT mice. In addition, absence of these cytokines did
not influence parasite accumulation in the whole body or isolated
organs during infection (Figures S9, S10 and S11).
Discussion
Pathologies induced by the malaria infection result from the
complex interplay between the parasite and the immune system
[6]. In particular, it has been proposed that IRBC sequestration,
resulting from the cytoadherence of IRBC to endothelium and
local inflammation, is the principal cause of pathogenesis [47].
Moreover, high P. falciparum parasite biomass representing both
circulating and sequestered parasites has been shown to be
associated with severity of the infection in humans [48]. In this
article, we have investigated the influence of immune cells and
cytokines of IRBC accumulation in various organs during
infection with PbA, an experimental model of CM.
We and others have previously reported that T cells, both CD4
+
and CD8
+, are essential for ECM to develop [22,41,49,50], CD4
+
T cells being involved in the induction phase and CD8
+ T cells in
the effector phase [22]. However their role in parasite growth and
distribution has not been clearly defined. In this study, we first
observed that RAG2
2/2 mice which lack T and B cells had a
reduced total parasite biomass and accumulated fewer parasites in
their brains during the first week of the infection but not at later
time points. Since these mice still have NK cells, this rules out a
direct role for these cells in IRBC accumulation or distribution in
tissues. Using deficient mice and antibody mediated-depletion, we
further showed that CD8
+ but not CD4
+ T cells mediate the
growth in total and head parasite biomass coinciding with ECM
development. In vivo parasite biomass measurements in the head
mirrored the reduction of IRBC accumulation in the brains
isolated from CD8
2/2 mice infected 7 days earlier (Figure 2F) and
from mice treated with anti-CD8
+ antibodies at day 6 post-
infection, just before ECM onset (Figure 3D). CD8
+ T cells have
previously been reported to be sequestered in the brain [21] when
PbA-infected mice displayed overt ECM signs, which is also when
we observed a surge in IRBC accumulation. We recently observed
that C57BL/6J ECM-susceptible mice have a higher parasite load
in the brain than ECM-resistant BALB/cJ mouse strain at the time
of ECM signs (Claser and Renia, unpublished). In the resistant
mouse strain, CD8
+ T cells also do not accumulate in the brain of
infected mice [22]. Taken together, this suggests that brain-
sequestered CD8
+ T cells are responsible for the time-dependent
accumulation of PbA IRBC.
How can CD8
+ T cells influence IRBC accumulation in tissues?
Although there is ample evidence that IRBC do accumulate in
tissues, the mechanism of accumulation is unknown [26–28]. In
humans infected with P. falciparum, sequestration of IRBC in deep
tissue results from their cytoadherence to endothelial cells [19].
However, this phenomenon has yet to be demonstrated in vivo or in
vitro for PbA. Different scenarios can be proposed to explain our
results. If PbA IRBC do cytoadhere, then it is possible that CD8
+
T cells, through direct interaction and/or release of mediators,
activate endothelial cells and favor binding of IRBC. We
previously proposed that binding of IRBC to activated cytokines
would leads to IRBC phagocytosis and processing and presenta-
tion to CD8+ T cells [51]. This would explain the implication of
perforin in ECM [50,52].
If PbA IRBC do not cytoadhere, then their accumulation may
result from hemodynamic disturbances or microhemorrhages.
One possible mechanism is the blockade of capillaries by other
cells also sequestered intravascularly. Monocytes and neutrophils
are the principal cell subsets sequestered in brain capillaries during
ECM [22]. They also have the capacity to phagocytose IRBC and
thus may carry undigested parasites. We used two experimental
systems (MAFIA mice and CCR2
2/2 mice treated with a
migration-blocking antibody) that allow significant reduction in
the numbers of these cell subsets in deep tissues. In both systems,
no modification of IRBC accumulation was observed (Figures 4
and S5). In addition, infected RAG2
2/2 mice that possess normal
monocyte and neutrophil compartments did accumulate fewer
IRBC than WT mice (Figures 1 and S2). This clearly demonstrates
that these two cell subsets were not responsible for IRBC
accumulation and that the CD8
+ T cell effect was not mediated
by these cells. We then tested the role of pro-inflammatory
cytokines, which have been shown to activate endothelial cells
during ECM [17]. We demonstrated that IFN-c, but not TNF-a
and IL-12, is involved in the control of IRBC accumulation in
tissues. Moreover, the effect of IFN-c was tissue-specific,
manifesting in the brain and to a lesser extent, the spleen, but
not in the other organs tested (Figures 5E, 5F and S6).
During completion of this work, two studies also reported a role
for CD8
+ T cells in controlling IRBC accumulation in the brains
[32] and other organs [32] of PbA-infected mice, thus confirming
our results. It is not known if IRBC accumulation during PbA
infection in deep tissues leads to organ-specific pathologies as has
Figure 4. Depletion of myeloid cells does not alter IRBC distribution during ECM. MAFIA mice were infected with PbAluc and injected on
days 5, 6, and 7 with the drug AP20187 as described in Material and Methods. (A) Depletion of granulocytes/monocytes (defined as
CD45
+CD11b
+Gr1
+) was assessed by flow cytometry on day 7 post-infection. Data plots presented are from one mouse and similar data were
obtained for 4 more mice. (B) Survival and (C) parasitemia of treated and non-treated MAFIA mice (5 per group). Neurologic signs of CM appeared on
days 6–12 (shaded area), with death occurring 24–48 h after onset. Parasitemia (%) values are expressed as mean 6 SD of 5 mice per group. In vivo
bioluminescence imaging quantification of IRBC accumulation in the whole body (D) and head (E) of treated and non-treated infected mice.
Luminescence values (log) as mean 6 SD of 5 mice.
doi:10.1371/journal.pone.0018720.g004
Immune Control of Parasite Accumulation in Tissues
PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18720Figure 5. IFN-c controls parasite biomass and IRBC accumulation in organs. (A) Survival and (B) parasitemia of WT and IFN-c
2/2 mice (5
mice per group) infected with PbAluc. Parasitemia (%) values are expressed as mean 6 SD. In vivo bioluminescence imaging quantification of IRBC
accumulation in the whole body (C) and head (D) of WT and IFN-c
2/2 mice. Luminescence values (log) as mean 6 SD of 5 mice. Ex vivo quantification
by bioluminescence imaging of IRBC accumulation in spleens (E) and brains (F) of perfused WT and IFN-c
2/2 mice obtained at day 7 and 8 post-
infections. Luminescence values (log) as mean 6 SD of 5 mice.
#p,0.01, log-rank test; *p,0.05, Mann Whitney test; *p,0.05, ANOVA followed by
Bonferroni test.
doi:10.1371/journal.pone.0018720.g005
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reported that CD8
+ T cells induce damage such as vascular
permeability in the lungs and kidneys during PbA infection in
C57BL/6J mice [21]. By extension to the brain, it is thus possible
that CD8
+-mediated IRBC accumulation may be responsible for
the various organ pathologies seen during ECM. Surprisingly,
although infected CD8
2/2 mice showed the same reduction in
IRCB accumulation in the spleen and brain as CD8-depleted
mice, there was no difference in other organs such as the heart,
lung, liver and kidneys at 7 to 10 days post-infection (Figures 2 and
S2). A possible explanation is the development of organ-specific
compensatory mechanisms in these mice since CD8
+ T cells were
absent from the start of the infection.
In our hands, PbA-infected-CD4
2/2 mice did not show much
modification of IRBC accumulation in tissues except for the spleen
as compared to WT mice. This contrasts with data reported very
recently by Amante et al. [32]. In this study, CD4
+ T cell depletion
was performed using antibody before and after infection and was
shown to modify parasite biomass to the same extent as CD8
+ T
cell depletion. We also observed differences for TNF-a between
the two studies. Amante et al. [32] found that a higher parasite
biomass in infected TNF-a KO mice. In our hands, TNF-a has no
effect on parasite accumulation in tissues (Figure S9). Quantitative
or qualitative differences in the parasite used or the route of
inoculation may account for the discrepancy between the two
studies, but more studies are needed to clarify this issue.
In conclusion, we have shown that CD8
+ T cells and IFN-c
mediate IRBC accumulation in the brain and in other organs
during ECM at the time when mice develop clinical signs.
Lymphotoxin-a has been shown by others also to be involved in
this pathogenic process [32] and essential for ECM to occur
[25,53]. This reveals a complex interplay between the parasite and
the immune system, defying an either-or choice between the
mechanical and immunological hypotheses of CM and supporting
an integrated mechanism. Our data open the way to new testable
hypotheses for the pathogenesis of human CM.
Supporting Information
Figure S1 Positioning of mice during measurement of
bioluminescence. Mice were injected with luciferin and placed
in a (A) ventral position for whole body imaging and (B) dorsal
position for head imaging.
(TIFF)
Figure S2 Reduced IRBC accumulation in the brains of
CD8
2/2 mice or CD8
+ T cell-depleted mice. Pseudocolor
images of isolated brains from perfused (A) CD4
2/2,C D 8
2/2,a n d
WT or (B) anti-CD4
+-treated, anti-CD8
+-treated and untreated mice.
(TIFF)
Figure S3 Reduced IRBC accumulation in different
organs of CD8
+ T cell-depleted mice. Quantification of
IRBC accumulation was performed in CD4
2/2, CD8
2/2, and
WT (A–D) or anti-CD4
+-treated, anti-CD8
+-treated and untreat-
ed (E–H) mice infected 7 days before. Mice were injected with
luciferin and IRBC accumulation was measured by biolumines-
cence imaging in organs obtained from perfused mice as described
in Materials and Methods. Luminescence values (log) as mean 6
SD of 5 mice per group. **p,0.01 and ***p,0.001, ANOVA
followed by Bonferroni post-test.
(TIFF)
Figure S4 Efficacy of granulocyte/monocyte depletion
in peripheral blood of MAFIA mice after treatment with
the drug AP20187. Mice were infected with PbAluc and injected
on day 5, 6, and 7 with the drug AP20187 as described in Material
and Methods. Depletion of granulocytes/monocytes (defined as
CD45
+CD11b
+Gr1
+) was assessed by flow cytometry on day 7
post-infection. Data plots presented are from one mouse and
similar data were obtained for 4 more mice.
(TIFF)
Figure S5 Depletion of myeloid cells does not reduce
IRBC accumulation in different organs of infected
MAFIA mice. MAFIA mice were infected with PbAluc and
injected on days 5, 6, and 7 with the drug AP20187 as described in
Material and Methods. (A–F) Ex vivo quantification by biolumi-
nescence imaging of IRBC accumulation in organs obtained from
perfused mice treated or not treated with the drug AP20187 at day
7 post-infection. Luminescence values (log) as mean 6 SD of 5
mice per group.
(TIFF)
Figure S6 Monocytes and neutrophils are not involved
in IRBC accumulation. (A) Survival and (B) parasitemia of
WT, anti-M-CSF-R antibody-treated and control CCR2
2/2 mice
infected with PbAluc. CCR2
2/2 mice received 2 mg of anti-M-
CSF-R (AFS98) antibody on days 5 and 6 post-infection.
Neurologic signs of CM appeared on days 7–10 (shaded area),
with death occurring 24–48 h after onset. Parasitemia (%) values
are expressed as mean 6 SD of 5 mice per group. In vivo
bioluminescence imaging quantification of IRBC accumulation in
the whole body (C) and head (D) of infected mice. Luminescence
values (log) as mean 6 SD of 5 mice per group.
(TIFF)
Figure S7 Reduced IRBC accumulation in the brains of
IFN-c
2/2 mice. Pseudocolor images of isolated brains from
perfused WT and IFN-c
2/2 mice at day 7 post-infection.
(TIFF)
Figure S8 IFN-c deficiency does not influence IRBC
accumulation in different organs. (A–D) IRBC accumula-
tion was determined by bioluminescence imaging of isolated
organs from perfused WT and IFN-c
2/2 mice infected with
PbAluc at days 7 and 8 post-infection. Luminescence values (log) as
mean 6 SD of 5 mice per group.
(TIFF)
Figure S9 TNF-a is not involved in IRBC accumulation in
the whole body and head. (A) Survival and (B) parasitemia of
WT and TNFa
2/2 mice infected with PbAluc. Neurologic signs of
CM appearedon days6–12 (shadedarea), with death occurring 24–
48 h after onset. Data are expressed as mean 6 SD of 5 mice per
group. Parasitemia (%) values are expressed as mean 6 SD of 5
mice per group. In vivo bioluminescence imaging quantification of
IRBC accumulation in the whole body (C) and head (D) of infected
mice. Data are expressed as mean 6 SD of 5 mice per group.
Luminescence values (log) as mean 6 SD of 5 mice per group.
(TIFF)
Figure S10 IL12 is not involved in IRBC accumulation in
the whole body and head. (A) Survival and (B) parasitemia of
WT (n=10) and IL12p40
2/2 (n=19) mice infected with PbAluc.
Neurologic signs of CM appeared on days 6–12 (shaded area),
with death occurring 24–48 h after onset. In WT mice,
neurological signs appear on day 8–12 (shaded area). Parasitemia
(%) values are expressed as mean 6 SD. In vivo bioluminescence
imaging quantification of IRBC accumulation in the whole body
(C) and head (D) of infected mice. Luminescence values (log) as
mean 6 SD of 5 mice.
(TIFF)
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accumulation in organs. (A–F) Quantification of IRBC
accumulation was performed in organs from perfused TNF-a
2/2,
IL12p40
2/2 mice and WT mice infected with PbAluc parasites 7
days before. Luminescence values (log) as mean 6 SD of 5 mice
per group.
(TIFF)
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